GB202005739D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB202005739D0
GB202005739D0 GBGB2005739.4A GB202005739A GB202005739D0 GB 202005739 D0 GB202005739 D0 GB 202005739D0 GB 202005739 A GB202005739 A GB 202005739A GB 202005739 D0 GB202005739 D0 GB 202005739D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2005739.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Enterprise Therapeutics Ltd
Original Assignee
Enterprise Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enterprise Therapeutics Ltd filed Critical Enterprise Therapeutics Ltd
Priority to GBGB2005739.4A priority Critical patent/GB202005739D0/en
Publication of GB202005739D0 publication Critical patent/GB202005739D0/en
Priority to CN202080053192.6A priority patent/CN114616226A/en
Priority to PCT/GB2020/051778 priority patent/WO2021014166A1/en
Priority to CA3145120A priority patent/CA3145120A1/en
Priority to EP20751234.4A priority patent/EP4003516A1/en
Priority to JP2022504089A priority patent/JP2022541311A/en
Priority to BR112022001164A priority patent/BR112022001164A2/en
Priority to MX2022000841A priority patent/MX2022000841A/en
Priority to PE2022000119A priority patent/PE20221441A1/en
Priority to KR1020227006371A priority patent/KR20220063162A/en
Priority to AU2020317036A priority patent/AU2020317036A1/en
Priority to CR20220072A priority patent/CR20220072A/en
Priority to CL2022000147A priority patent/CL2022000147A1/en
Priority to US17/581,504 priority patent/US20220235006A1/en
Priority to IL290035A priority patent/IL290035A/en
Priority to CONC2022/0002022A priority patent/CO2022002022A2/en
Ceased legal-status Critical Current

Links

GBGB2005739.4A 2019-07-24 2020-04-20 Compounds Ceased GB202005739D0 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
GBGB2005739.4A GB202005739D0 (en) 2020-04-20 2020-04-20 Compounds
CR20220072A CR20220072A (en) 2019-07-24 2020-07-24 Pyridine derivatives as tmem16a modulators for use in the treatment of respiratory conditions
BR112022001164A BR112022001164A2 (en) 2019-07-24 2020-07-24 Compound, use of a compound, method for the treatment or prophylaxis of diseases, compound for use and pharmaceutical composition
PE2022000119A PE20221441A1 (en) 2019-07-24 2020-07-24 PYRIDINE DERIVATIVES AS TMEM16A MODULATORS FOR USE IN THE TREATMENT OF RESPIRATORY DISEASES
CA3145120A CA3145120A1 (en) 2019-07-24 2020-07-24 Pyridine derivatives as tmem16a modulators for use in the treatment of respiratory conditions
EP20751234.4A EP4003516A1 (en) 2019-07-24 2020-07-24 Pyridine derivatives as tmem16a modulators for use in the treatment of respiratory conditions
JP2022504089A JP2022541311A (en) 2019-07-24 2020-07-24 Pyridine derivatives as TMEM16A modulators for use in treating respiratory symptoms
CN202080053192.6A CN114616226A (en) 2019-07-24 2020-07-24 Pyridine derivatives as TMEM16A modulators for the treatment of respiratory disorders
MX2022000841A MX2022000841A (en) 2019-07-24 2020-07-24 Pyridine derivatives as tmem16a modulators for use in the treatment of respiratory conditions.
PCT/GB2020/051778 WO2021014166A1 (en) 2019-07-24 2020-07-24 Pyridine derivatives as tmem16a modulators for use in the treatment of respiratory conditions
KR1020227006371A KR20220063162A (en) 2019-07-24 2020-07-24 Pyridine derivatives as TMEM16A modulators for use in the treatment of respiratory conditions
AU2020317036A AU2020317036A1 (en) 2019-07-24 2020-07-24 Pyridine derivatives as TMEM16A modulators for use in the treatment of respiratory conditions
US17/581,504 US20220235006A1 (en) 2019-07-24 2022-01-21 Pyridine derivatives as tmem16a modulators for use in the treatment of respiratory conditions
CL2022000147A CL2022000147A1 (en) 2019-07-24 2022-01-21 Pyridine derivatives as modulators of tmem16a for use in the treatment of respiratory conditions.
IL290035A IL290035A (en) 2019-07-24 2022-01-23 Pyridine derivatives as tmem16a modulators for use in the treatment of respiratory conditions
CONC2022/0002022A CO2022002022A2 (en) 2019-07-24 2022-02-24 Pyridine derivatives as modulators of tmem16a for use in the treatment of respiratory conditions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2005739.4A GB202005739D0 (en) 2020-04-20 2020-04-20 Compounds

Publications (1)

Publication Number Publication Date
GB202005739D0 true GB202005739D0 (en) 2020-06-03

Family

ID=70860021

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2005739.4A Ceased GB202005739D0 (en) 2019-07-24 2020-04-20 Compounds

Country Status (1)

Country Link
GB (1) GB202005739D0 (en)

Similar Documents

Publication Publication Date Title
GB202016614D0 (en) Compounds
GB202014944D0 (en) Compounds
GB202106130D0 (en) Compounds
GB202105942D0 (en) Compounds
GB202105000D0 (en) Compounds
GB202103874D0 (en) Compounds
GB202103704D0 (en) Compounds
GB202103482D0 (en) Compounds
GB202103012D0 (en) Compounds
GB202103017D0 (en) Compounds
GB202103008D0 (en) Compounds
GB202102709D0 (en) Compounds
GB202100645D0 (en) Compounds
GB202020370D0 (en) Compounds
GB202020047D0 (en) Compounds
GB202019429D0 (en) Compounds
GB202019428D0 (en) Compounds
GB202019427D0 (en) Compounds
GB202018034D0 (en) Compounds
GB202017630D0 (en) Compounds
GB202017406D0 (en) Compounds
GB202016977D0 (en) Compounds
GB202016245D0 (en) Compounds
GB202014255D0 (en) Compounds
GB202013558D0 (en) GRP52 Modularor compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)